- Home
- MODV vs MURA Comparison
MODV vs MURA Comparison
Compare MODV & MURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODV
- MURA
- Stock Information
- Founded
- MODV 1996
- MURA 2013
- Country
- MODV United States
- MURA Ireland
- Employees
- MODV N/A
- MURA N/A
- Industry
- MODV Transportation Services
- MURA
- Sector
- MODV Consumer Discretionary
- MURA
- Exchange
- MODV Nasdaq
- MURA Nasdaq
- Market Cap
- MODV 48.9M
- MURA 45.8M
- IPO Year
- MODV N/A
- MURA N/A
- Fundamental
- Price
- MODV $3.32
- MURA $2.46
- Analyst Decision
- MODV Buy
- MURA Strong Buy
- Analyst Count
- MODV 4
- MURA 3
- Target Price
- MODV $9.17
- MURA $12.00
- AVG Volume (30 Days)
- MODV 1.1M
- MURA 95.5K
- Earning Date
- MODV 08-06-2025
- MURA 08-12-2025
- Dividend Yield
- MODV N/A
- MURA N/A
- EPS Growth
- MODV N/A
- MURA N/A
- EPS
- MODV N/A
- MURA N/A
- Revenue
- MODV $2,753,789,000.00
- MURA N/A
- Revenue This Year
- MODV N/A
- MURA N/A
- Revenue Next Year
- MODV $4.90
- MURA N/A
- P/E Ratio
- MODV N/A
- MURA N/A
- Revenue Growth
- MODV N/A
- MURA N/A
- 52 Week Low
- MODV $0.87
- MURA $0.95
- 52 Week High
- MODV $32.82
- MURA $4.74
- Technical
- Relative Strength Index (RSI)
- MODV 59.45
- MURA 46.96
- Support Level
- MODV $3.01
- MURA $2.43
- Resistance Level
- MODV $3.74
- MURA $2.64
- Average True Range (ATR)
- MODV 0.43
- MURA 0.09
- MACD
- MODV -0.01
- MURA 0.01
- Stochastic Oscillator
- MODV 60.58
- MURA 33.04
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. Its solutions address the social determinants of health (SDoH) by connecting members to essential care services. Its various service offerings include non-emergency medical transportation, personal care, virtual and remote monitoring, consumer health engagement, and integrated supportive care. The company's reportable segments are NEMT, PCS, Monitoring, and Corporate and Other. A majority of its revenue is generated from the NEMT segment, which provides non-emergency medical transportation services.
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.